drugset / Trial / NCT03035942

Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration

NCT03035942

Phase 4 Completed 135 enrolled Pontifical Catholic University of São Paulo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to evaluate not only the occurrence of side effects, but the quality of the recovery (QoR-40 Questionnaire) of patients submitted to spinal anesthesia with administration of low doses (0.1 mg) of intrathecal morphine for the surgical treatment of fractures in one of the lower limbs and who will receive prophylactic ondansetron (4mg), dexamethasone (8mg) or placebo.

Timeline

Start
2017-01-02
Primary completion
2018-10-01
Completion
2019-11-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg
Subject Ondansetron Other / unclassified 4 mg